Results 111 to 120 of about 971 (151)

Clopidogrel and Aspirin Resistance and Its Interaction with Peripheral Arterial Disease Outcomes in the Indian Population

Vikram Patra, Rohit Mehra, C V N M Dattatraya, Rishi Dhillan, Anuka Sharma, Varun Sharma, Brijesh Biswas, Ajay Kumar Dabas, Rahul Merkhed   +8 more
openalex   +1 more source

Prevalence of Aspirin or Clopidogrel Pharmacological Resistance in Ischemic Stroke: A Step Toward Precision Medicine

Samantha Cencer, Laurel Packard, Alan T. Davis, Asad Ahrar, Małgorzata Miller, Nadeem Khan, Nabil Wees, Jiangyong Min   +7 more
openalex   +1 more source

TCT-76: The Clopidogrel Resistance in Stent Thrombosis (CREST) Registry: The Case for Personalized Antiplatelet Therapy?

, 2011

openalex   +1 more source

“RESISTANCE” OR HIGH ON-TREATMENT PLATELET REACTIVITY TO ASPIRIN AND CLOPIDOGREL IN PATIENTS WITH CRITICAL LIMB ISCHEMIA

, 2012
Sarah Elsayed, David M. Shavelle, Ray Matthews, Leonardo Clavijo   +3 more
openalex   +1 more source

Obesity, Leptin and Thrombosis: Focus on clopidogrel resistance

Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2016
openaire   +4 more sources

Some of the next articles are maybe not open access.

Related searches:

Clopidogrel Resistance

Heart, Lung and Circulation, 2007
Clopidogrel resistance has been used as one of the terms employed in the literature to describe different degrees of ex vivo low platelet inhibition after clopidogrel administration. In addition to the diverse nomenclature, the characterisation of clopidogrel resistance has also been problematic because different authors have given different ...
Ernesto, Oqueli, Martin, Hiscock, Ronald, Dick   +2 more
openaire   +4 more sources

Clopidogrel Resistance: Fact and Fiction [PDF]

Future Cardiology, 2006
The antiplatelet agent clopidogrel in combination with aspirin has been shown to reduce thrombotic events in patients with acute coronary syndromes and/or who are undergoing percutaneous coronary intervention. However, a large interindividual response variability to clopidogrel has been described.
Christian M. Hackeng, J. W. Van Werkum, J. M. ten Berg, A. A. C. M. Heestermans, V.H.M. Deneer   +4 more
openaire   +2 more sources

Clopidogrel resistance: A diagnostic challenge

International Journal of Cardiology, 2009
No clear and generally accepted definition of clopidogrel resistance has been achieved up to now. We believe that the new point-of-care assays of platelet function may help the clinicians to overcome to define clopidogrel resistance especially in patients undergoing percutaneous coronary intervention in whom the level of inhibition of platelets is ...
Husamettin Gul, Atila Iyisoy, Ersoy Isik, Turgay Celik   +3 more
openaire   +3 more sources

Clinical implications of clopidogrel resistance

Thrombosis and Haemostasis, 2008
SummaryThe benefits of clopidogrel in the treatment and prevention of coronary artery disease are well established, however, not all individuals respond in the same way to clopidogrel; there are patients who suffer adverse events despite clopidogrel treatment.
Borja Ibanez, Antonio De Miguel, Juan J. Badimon   +2 more
openaire   +2 more sources

The “Clopidogrel Resistance” Trap

The American Journal of Cardiology, 2007
a p w b e p “ S b s “ t a s i n i v t p m d e o n s u a b o b b S f d v r p e w a a ( r d p d Q v f t o w o Numerous randomized trials have indicated the benefits f clopidogrel either as an alternative1 or as an adjunct2 to spirin for the secondary prevention of acute vascular vents, including absolute mortality reduction in the largest ver acute ...
openaire   +3 more sources